ILC3s are the least abundant lymphocyte subset in atherosclerosis, and its dependence on the transcription factor RORγt for the production of IL-17 and IL-22 on the effects of atherosclerosis has been inconsistently investigated, leading to our lack of clarity on the role of ILC3s in atherosclerosis (41). This evidence concerns the gene IL17A and atherosclerosis.